Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
| Title: | Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma |
|---|---|
| Authors: | Powles, ThomasAff1, IDs1288502108630w_cor1; Choueiri, Toni K.Aff2; Motzer, Robert J.Aff3; Jonasch, EricAff4; Pal, SumantaAff5; Tannir, Nizar M.Aff4; Signoretti, SabinaAff6; Kaldate, RajeshAff7; Scheffold, ChristianAff7; Wang, EvelynAff7; Aftab, Dana T.Aff7; Escudier, BernardAff8; George, Daniel J.Aff9 |
| Source: | BMC Cancer. 21(1) |
| Database: | Springer Nature Journals |